SCHEMBL29381982

SCHEMBL29381982

CN(C)CCCCNC(=O)C=Cc1ccccc1Sc1ccc(Cl)cc1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC1 Q13547 1/20 0.61
HDAC8 Q9BY41 1/20 0.61
HDAC6 Q9UBN7 1/20 0.61
ITGB2 P05107 9/20 0.57
ICAM1 P05362 9/20 0.57
ITGAL P20701 9/20 0.57
MEN1 O00255 6/20 0.46
KMT2A Q03164 6/20 0.46
MAPT P10636 2/20 0.46
LMNA P02545 3/20 0.45
ALDH1A1 P00352 3/20 0.45
HPGD P15428 2/20 0.45
CYP1A2 P05177 2/20 0.43
CYP2C9 P11712 1/20 0.43
CYP2C19 P33261 1/20 0.43
HTT P42858 1/20 0.43
KDM4E B2RXH2 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
SLC6A4 P31645 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1020786 1.00 HDAC1 (0.61) HDAC1HDAC8HDAC6ITGB2ICAM1
SCHEMBL5019656 1.00 HDAC1 (0.61) HDAC1HDAC8HDAC6ITGB2ICAM1
SCHEMBL1020787 1.00 HDAC1 (0.61) HDAC1HDAC8HDAC6ITGB2ICAM1
Hydrochloric Acid SCHEMBL29478485 0.99 HDAC6 (0.60) HDAC1HDAC8HDAC6ITGB2ICAM1
SCHEMBL23666454 0.93 HDAC1 (0.65) HDAC1HDAC8HDAC6ITGB2ICAM1
SCHEMBL17132276 0.91 KMT2A (0.51) HDAC1HDAC8HDAC6ITGB2ICAM1
SCHEMBL6763024 0.87 HDAC1 (0.67) HDAC1HDAC8HDAC6ITGB2ICAM1
SCHEMBL6763018 0.87 HDAC1 (0.67) HDAC1HDAC8HDAC6ITGB2ICAM1
SCHEMBL6759553 0.87 ITGB2 (0.74) HDAC1HDAC8HDAC6ITGB2ICAM1
SCHEMBL6759557 0.87 ITGB2 (0.74) HDAC1HDAC8HDAC6ITGB2ICAM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114144229-A Methods and materials for gender-dependent treatment of cardiovascular dysfunction 梅约医学教育与研究基金会 2022-03-04 CN claimed
EP-3952992-A1 METHODS AND MATERIALS FOR GENDER-DEPENDENT TREATMENT OF CARDIOVASCULAR DYSFUNCTION Mayo Foundation for Medical Education and Research (US) 2022-02-16 EP claimed
CN-114144229-A Methods and materials for gender-dependent treatment of cardiovascular dysfunction 梅约医学教育与研究基金会 2022-03-04 CN disclosed
EP-3952992-A1 METHODS AND MATERIALS FOR GENDER-DEPENDENT TREATMENT OF CARDIOVASCULAR DYSFUNCTION Mayo Foundation for Medical Education and Research (US) 2022-02-16 EP disclosed